AI assistant
DEVEX RESOURCES LIMITED — Share Issue/Capital Change 2012
Feb 20, 2012
64768_rns_2012-02-20_de85c2f2-667b-4d58-a7c3-1808a8ac6f0f.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
21 February 2012
The Company Announcement Officer Australian Securities Exchange Ltd via electronic lodgement
Uranium Equities engages Boswell Capital
The Company has entered an Advisory Services Agreement with Boswell Capital Corporation to provide corporate advice and investor relations services with a focus on the North American investment markets where the Company’s PhosEnergy Process has attracted significant interest.
Boswell Capital is a Toronto based Exempt Market Dealer regulated under the Ontario Securities Commission providing corporate finance solutions, analytical support and strategic advice to both public and private firms in the extractive industries with a particular specialty in Uranium markets. Boswell will support the company as it continues to demonstrate its unique PhosEnergy Process and further advance its core uranium exploration properties.
Pursuant to the agreement, the Company has issued unlisted options to Boswell with the following key terms:
| Number: | 300,000 |
|---|---|
| Exercise Price: | $0.078 |
| Expiry: | 21 February 2014 |
Our Strengths
-
PhosEnergy Process – Low cost by-product uranium recovery
-
Nabarlek Project – A highly endowed uranium region
-
Multiple near term growth opportunities
See the Appendix 3B attached for further details.
Yours faithfully,
Bryn Jones Managing Director
HEAD OFFICE Level 5 29 King William Street Adelaide, SA 5000 T: +61 8 8110 0700 F: +61 8 8110 0777 E: [email protected]
PERTH OFFICE Level 2, 1292 Hay Street West Perth, WA 6005 GPO Box 2890 Perth, WA 6001 T: +61 8 9322 3990 F: +61 8 9322 5800
w w w . u e l . c o m . a u
Appendix 3B New issue announcement
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement, application for quotation of additional securities and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005.
Name of entity
Uranium Equities Limited
ABN
74 009 799 553
We (the entity) give ASX the following information.
Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough space).
| 1 +Class of+securities issued or to be issued 2 Number of+securities issued or to be issued (if known) or maximum number which may be issued 3 Principal terms of the+securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion) |
Unlisted options to acquire fully paid ordinary shares |
|---|---|
| 300,000 unlisted options | |
| The exercise price is $0.078 and the expiry date is 21 February 2014. The options vest immediately. |
- See chapter 19 for defined terms.
24/10/2005 Appendix 3B Page 1
Appendix 3B New issue announcement
| 4 Do the+securities rank equally in all respects from the date of allotment with an existing+class of quoted +securities? If the additional securities do not rank equally, please state: the date from which they do the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or consideration 6 Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) 7 Dates of entering +securities into uncertificated holdings or despatch of certificates 8 Number and +class of all +securities quoted on ASX (including the securities in clause 2 if applicable) |
No - Unlisted options not quoted. | No - Unlisted options not quoted. |
|---|---|---|
| Nil | ||
| 300,000 unlisted options have been issued to a corporate advisor pursuant to an advisory services agreement. |
||
| 21 February 2012 | ||
| Number | +Class | |
| 252,312,961 | Ordinary Fully Paid Shares |
- See chapter 19 for defined terms.
Appendix 3B Page 2
1/1/2003
Appendix 3B New issue announcement
| 9 Number and+class of all +securities not quoted on ASX (including the securities in clause 2 if applicable) 10 Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests) |
Number | +Class | +Class |
|---|---|---|---|
| 100,000 500,000 2,300,000 750,000 500,000 1,900,000 875,000 3,000,000 1,300,000 500,000 300,000 |
Unlisted options Exercise Price $0.60 $0.60 $0.30 $0.45 $0.30 $0.30 $0.25 $0.25 $0.25 $0.25 $0.078 |
Expiry 21.06.2012 15.11.2012 01.03.2013 01.03.2013 02.12.2013 01.07.2012 15.11.2013 25.11.2013 07.07.2014 24.11.2014 21.02.2014 |
|
| N/A |
Part 2 - Bonus issue or pro rata issue
11 Is security holder approval N/A required? 12 Is the issue renounceable or nonN/A renounceable? 13 Ratio in which the[+] securities N/A will be offered 14 +Class of +securities to which the N/A offer relates 15 +Record date to determine N/A entitlements 16 Will holdings on different N/A registers (or subregisters) be aggregated for calculating entitlements? 17 Policy for deciding entitlements N/A in relation to fractions
- See chapter 19 for defined terms.
24/10/2005 Appendix 3B Page 3
Appendix 3B New issue announcement
| 18 Names of countries in which the entity has+security holders who will not be sent new issue documents Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7. 19 Closing date for receipt of acceptances or renunciations 20 Names of any underwriters 21 Amount of any underwriting fee or commission 22 Names of any brokers to the issue 23 Fee or commission payable to the broker to the issue 24 Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of+security holders 25 If the issue is contingent on +security holders’ approval, the date of the meeting 26 Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled 27 If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders 28 Date rights trading will begin (if applicable) 29 Date rights trading will end (if applicable) |
N/A |
|---|---|
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A |
- See chapter 19 for defined terms.
Appendix 3B Page 4
1/1/2003
Appendix 3B New issue announcement
-
30 How do[+] security holders sell N/A their entitlements in full through a broker?
-
31 How do[+] security holders sell N/A part of their entitlements through a broker and accept for the balance?
-
32 How do[+] security holders dispose of their entitlements (except by sale through a broker)?
N/A
- 33 +Despatch date
N/A
Part 3 - Quotation of securities
You need only complete this section if you are applying for quotation of securities
-
34 Type of securities ( tick one )
-
(a)[Securities described in Part 1 ]
-
(b)[All other securities ]
Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or documents
35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders
36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000
- See chapter 19 for defined terms.
24/10/2005 Appendix 3B Page 5
Appendix 3B New issue announcement
100,001 and over
37 A copy of any trust deed for the additional[+] securities
Entities that have ticked box 34(b)
| 38 Number of securities for which +quotation is sought 39 Class of +securities for which quotation is sought 40 Do the+securities rank equally in all respects from the date of allotment with an existing+class of quoted+securities? If the additional securities do not rank equally, please state: the date from which they do the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 41 Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another security, clearly identify that other security) 42 Number and +class of all +securities quoted on ASX (_including_the securities in clause 38) |
N/A | |
|---|---|---|
| N/A | ||
| N/A | ||
| N/A | ||
| Number | +Class | |
| N/A |
- See chapter 19 for defined terms.
Appendix 3B Page 6
1/1/2003
Appendix 3B New issue announcement
Quotation agreement
-
1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.
-
2 We warrant the following to ASX.
-
The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.
-
There is no reason why those[+] securities should not be granted +quotation.
-
An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
-
Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.
-
If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.
-
3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
-
4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
Sign here: ........................... Date: 21 February 2012 Company Secretary
Print name: Rolf Heinrich
- See chapter 19 for defined terms.
24/10/2005 Appendix 3B Page 7